Indaptus Therapeutics (INDP) Cash from Investing Activities (2020 - 2023)

Indaptus Therapeutics' Cash from Investing Activities history runs 4 years deep, the most recent figure standing at $7.0 million for Q3 2023.

• In Q3 2023, Cash from Investing Activities rose 338.17% year-over-year to $7.0 million; the TTM figure through Dec 2023 stood at $17.1 million (up 204.34% YoY), while the FY2023 annual figure was $17.1 million, up 204.34% from the prior year.
• Cash from Investing Activities for Q3 2023 stood at $7.0 million, down from $8.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $8.0 million in Q2 2023, with the low at -$15.8 million in Q2 2022.
• The 4-year median for Cash from Investing Activities is $225300.0 (2021), against an average of $160858.0.
• Peak annual rise in Cash from Investing Activities reached 1033.64% in 2022, while the deepest fall reached 1317344.75% in 2022.
• Indaptus Therapeutics' Cash from Investing Activities stood at $769000.0 in 2020, then tumbled by 41.27% to $451600.0 in 2021, then jumped by 1033.64% to $5.1 million in 2022, then surged by 36.73% to $7.0 million in 2023.
• Business Quant data shows INDP's Cash from Investing Activities at $7.0 million in Q3 2023, $8.0 million in Q2 2023, and $2.1 million in Q1 2023.